Grupo de Investigación en Fisiopatología Cardiovascular
CTS237
Hospital Universitario Puerta del Mar
Cádiz, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (29)
2023
-
Survival Outcomes in Palliative Sedation Based on Referring Versus On-Call Physician Prescription
Journal of Clinical Medicine, Vol. 12, Núm. 16
2021
-
Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?
International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260
-
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810
2018
-
El reto de comenzar a impartir cuidados paliativos en una facultad de medicina. ¿Es útil esta materia para los futuros médicos?
Medicina Paliativa, Vol. 25, Núm. 1, pp. 1-6
2017
-
Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494
-
Relevancia del soporte nutricional especializado en las declaraciones de voluntades anticipadas. Experiencia de un centro hospitalario de especialidades
Nutricion Hospitalaria, Vol. 34, Núm. 1, pp. 6-14
2015
-
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 34, Núm. 9, pp. 1879-1884
2014
-
Clinical and virological efficacy of etravirine plus two active nucleos(t)ide analogs in an heterogeneous HIV-infected population
PLoS ONE, Vol. 9, Núm. 5
-
Predictors of early mortality in very elderly patients with bacteremia: A prospective multicenter cohort
International Journal of Infectious Diseases, Vol. 26, pp. 83-87
2013
-
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis
Clinical Infectious Diseases, Vol. 56, Núm. 11, pp. 1646-1653
-
Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: A prospective cohort study
BMC Infectious Diseases, Vol. 13, Núm. 1
-
Short communication: Atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C
AIDS Research and Human Retroviruses, Vol. 29, Núm. 2, pp. 223-225
2012
-
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
AIDS, Vol. 26, Núm. 13, pp. 1721-1724
-
Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: A propensity score-based analysis
Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 1, pp. 472-478
-
Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis
Clinical Infectious Diseases, Vol. 55, Núm. 12, pp. 1719-1726
2010
-
Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals
Clinical Microbiology and Infection, Vol. 16, Núm. 9, pp. 1408-1413
2008
-
Diagnostic and therapeutic protocol of toxic megacolon
Medicine
-
Large bowel tumors
Medicine, Vol. 10, Núm. 7, pp. 442-448
2007
-
Arthritis due to Mycobacterium kansasii in a woman with human immunodeficiency virus infection [1]
Enfermedades Infecciosas y Microbiologia Clinica
-
Diagnostic methods in the detectiion of prostate cancer: Prospective observational study
Current Medical Imaging Reviews, Vol. 3, Núm. 1, pp. 27-35